Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice.
Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice.
复制标题
DOI:
10.3389/fphar.2021.644387
复制
发表时间:
2021
影响因子:
5.6
通讯作者:
Li C
中科院分区:
文献类型:
--
作者:
Zhao L;Du X;Tian J;Kang X;Li Y;Dai W;Li D;Zhang S;Li C
Inflammatory bowel disease (IBD) is a refractory disorder characterized by chronic and recurrent inflammation. The progression and pathogenesis of IBD is closely related to oxidative stress and irregularly high concentrations of reactive oxygen species (ROS). A new oxidation-responsive nano prodrug was constructed from a phenylboronic esters-modified carboxylmethyl chitosan (OC-B) conjugated with berberine (BBR) that degrades selectively in response to ROS. The optimized micelles exhibited well-controlled physiochemical properties and stability in a physiological environment. OC-B-BBR micelles could effectively encapsulate the anti-inflammatory drug berberine and exhibit ideal H2O2-triggered release behavior as confirmed by in vitro drug loading and release studies. The in vivo anti-inflammatory effect and regulation of gut microbiota caused by it were explored in mice with colitis induced by dextran sodium sulfate (DSS). The results showed that OC-B-BBR significantly ameliorated colitis symptoms and colon damage by regulating the expression levels of IL-6 and remodeling gut microbiota. In summary, this study exhibited a novel BBR-loaded Carboxylmethyl Chitosan nano delivery system which may represent a promising approach for improving IBD treatment.
登录
查看更多内容
影响因子:
15
作者:
Yik-Sham Chung C;Timblin GA;Saijo K;Chang CJ
通讯作者:
Chang CJ
影响因子:
14.8
作者:
Wirtz, Stefan;Neufert, Clemens;Neurath, Markus F.
通讯作者:
Neurath, Markus F.
影响因子:
--
作者:
Tian T;Wang Z;Zhang J
通讯作者:
Zhang J
影响因子:
29.7
作者:
Kaser A;Zeissig S;Blumberg RS
通讯作者:
Blumberg RS
影响因子:
5.6
作者:
Cui H;Cai Y;Wang L;Jia B;Li J;Zhao S;Chu X;Lin J;Zhang X;Bian Y;Zhuang P
通讯作者:
Zhuang P